StockData
Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc. (NRIX) stock

NRIXNasdaqPharmaceutical PreparationsFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 13, 2026Score 15/3072% below fair value
$14.73−0.75 (-4.84%)

Close on Nov 16, 2026Market cap $1.61BP/E 6.4Yield 0.00%

Nurix Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Nurix Therapeutics's market cap was $1.78B on Nov 11, 2026, against $1.36B a year earlier. Over the last 5 years it ranged from $271.14M to $2.93B, with a median of $810.38M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.78B+22.3%
2025Dec 31, 2025$1.46B+15.4%
2024Dec 31, 2024$1.26B+152.5%
2023Dec 29, 2023$500.56M-3.3%
2022Dec 30, 2022$517.68M-59.9%
2021Dec 31, 2021$1.29B+1.0%
2020Dec 31, 2020$1.28B–

More Nurix Therapeutics figures

See a number that looks wrong?